Complete Response
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study on the Applicability of CCR Criteria in Rectal Cancer (NCT06794099) | Peking University Cancer Hospital & Institute | 2019-01-01 |
| Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy. (NCT01844986) | AstraZeneca | 2013-08-26 |
Track Complete Response automatically
Every clearance here is in the API, with alerts when new ones post.